Budget Impact of RefluxStop™ as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom
# Background Gastro-oesophageal reflux disease (GORD) is a common condition associated with heartburn and regurgitation. Standard of care for GORD patients in the UK involves initial treatment with proton pump inhibitors (PPIs) and laparoscopic antireflux surgery in patients unwilling to continue or...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Columbia Data Analytics, LLC
2024-01-01
|
| Sarja: | Journal of Health Economics and Outcomes Research |
| Linkit: | https://doi.org/10.36469/001c.90924 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|